Trial Profile
A randomized, double-blind, controlled study of KIB-PCI in Japanese healthy adult volunteers
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Jun 2016
Price :
$35
*
At a glance
- Drugs Influenza A virus vaccine-H5N1 (Primary)
- Indications Influenza A virus H5N1 subtype
- Focus Pharmacodynamics; Registrational
- Sponsors Daiichi Sankyo Company; Kitasato Daiichi Sankyo Vaccine
- 06 Jun 2016 New trial record